BackgroundThe heterogeneity of cancer makes it challenging to predict its response to immunotherapy. highlighting the need to find reliable biomarkers for assessment. The sophisticated role of cancer stemness in mediating resistance to immune checkpoint inhibitors (ICIs) is still inadequately comprehended. MethodsGenome-scale CRISPR screening of RNA sequencing data from Project Achill... https://www.nacrack.com/